Given the regulatory capacity of miRNAs, lncRNAs, and circRNAs in influencing GATA factor expression and function, synthetic RNA molecules such as antisense oligo-nucleotides and RNA interference agents could be tailored to counteract GATA-related transcriptional abnormalities in cancer. Here, QRSL1 is linked to cancer.